Get the Stockscreener App
0.40
5.26%
+0.02
Agile Therapeutics Inc stock is currently priced at $0.40, with a 24-hour trading volume of 85,721.
It has seen a +5.26% increased in the last 24 hours and a -68.24% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $0.381 pivot point. If it approaches the $0.408 resistance level, significant changes may occur.
Previous Close:
$0.38
Open:
$0.373
24h Volume:
85,721
Market Cap:
$N/A
Revenue:
$19.97M
Net Income/Loss:
$-13.93M
P/E Ratio:
-0.0101
EPS:
-39.56
Net Cash Flow:
$-11.31M
1W Performance:
-5.99%
1M Performance:
-68.24%
6M Performance:
-88.75%
1Y Performance:
-97.59%
1D Range:
$0.373
$0.42
52W Range:
$0.368
$0.42
Agile Therapeutics Inc Stock (AGRX) Company Profile
Agile Therapeutics Inc Stock (AGRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Apr-12-19 | Resumed | Janney | Buy |
| Nov-29-18 | Initiated | Maxim Group | Buy |
| Dec-26-17 | Downgrade | Janney | Buy → Neutral |
| Dec-26-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-02-17 | Resumed | H.C. Wainwright | Buy |
| Sep-14-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-19-17 | Initiated | H.C. Wainwright | Buy |
| Jan-08-16 | Initiated | Cantor Fitzgerald | Buy |
| Apr-02-15 | Initiated | FBR Capital | Outperform |
| Jun-17-14 | Initiated | RBC Capital Mkts | Outperform |
| Jun-17-14 | Initiated | William Blair | Outperform |
View All
Agile Therapeutics Inc Stock (AGRX) Latest News
Agile Therapeutics Announces Delisting from Nasdaq
GlobeNewswire Inc.
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
GlobeNewswire Inc.
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
GlobeNewswire Inc.
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
GlobeNewswire Inc.
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
GlobeNewswire Inc.
Agile Therapeutics Inc Stock (AGRX) Financials Data
Agile Therapeutics Inc (AGRX) Revenue 2024
AGRX reported a revenue (TTM) of $19.97 million for the quarter ending September 30, 2023, a +137.70% rise year-over-year.
Agile Therapeutics Inc (AGRX) Net Income 2024
AGRX net income (TTM) was -$13.93 million for the quarter ending September 30, 2023, a +66.04% increase year-over-year.
Agile Therapeutics Inc (AGRX) Cash Flow 2024
AGRX recorded a free cash flow (TTM) of -$11.31 million for the quarter ending September 30, 2023, a +77.91% increase year-over-year.
Agile Therapeutics Inc (AGRX) Earnings per Share 2024
AGRX earnings per share (TTM) was -$13.33 for the quarter ending September 30, 2023, a +97.89% growth year-over-year.
2.03%
4.37%
Cap:
|
Volume (24h):